MARLBOROUGH, Mass. 14 October--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 [...]
In the United States alone, an estimated 10-12 million adults live with moderate to severe chronic neuropathic pain. The effects can be debilitating, leading not only to extreme physical discomfort, but also psychological distress, social isolation, reduced worker productivity and an overall decrease in quality of life. [...]
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for [...]
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. [...]
KIRKLAND, Wash. July 24, 2024 08:00 AM Eastern Daylight--(BUSINESS WIRE)-- Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with [...]
QUINCY, Mass. July 10, 2024. IntelyCare, the healthcare industry’s most comprehensive nurse talent platform, today announced that it has appointed Matthew Levesque as the new Chief Executive Officer and member of the Board of Directors. A veteran healthcare executive known for scaling mission-driven organizations, Levesque will lead the expansion [...]
Basel, 9th July 2024. Medartis today announced that its Board has appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. Matthias will succeed Christoph Brönnimann, who will ensure a seamless transition. Matthias brings excellent knowledge of the global medical technology sector, having held [...]
The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management. Horw, Switzerland, June 18, 2024 - CeQur®, a medical device company dedicated to simplifying insulin delivery for individuals on multiple daily injections, announces [...]
European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment Boston, MA and Rolle, Switzerland, April 17, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the [...]
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Medartis successfully places CHF 115.8 million convertible bonds due 2031 Basel, 4 April 2024: [...]